BANK OF AMERICA CORP /DE/
BankPosition in TAK — Takeda Pharmaceutical Co Ltd
CIK 70858
CHARLOTTE, NC
Position in TAK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,926,210
-$999,615 QoQ
Shares Held
307,312
-4.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 376 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $1,596,028,663 across 49 Drug Manufacturers - Specialty & Generic names. TAK ranks #29 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,924,926 | $282,045,178 | |
| 2 | LQDA |
Liquidia Corp
|
1,991,566 | $158,787,554 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,227,607 | $143,231,322 | |
| 4 | VTRS |
Viatris Inc
|
7,356,708 | $116,824,520 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
619,352 | $104,385,582 | |
| 6 | HLN |
Haleon plc
|
10,850,097 | $101,231,403 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
179,235 | $97,114,896 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
3,909,871 | $96,221,922 |
All Filings in TAK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,926,210 | 307,312 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,925,825 | 319,969 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $5,657,109 | 362,868 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,392,641 | 368,350 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $16,034,536 | 1,037,163 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,733,981 | 318,358 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,799,721 | 362,517 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $12,745,127 | 896,282 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,219,741 | 867,059 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $20,612,880 | 1,484,009 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $11,905,644 | 834,313 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $34,038,298 | 2,200,278 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $13,281,624 | 845,425 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $21,371,872 | 1,296,837 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $13,366,655 | 856,837 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $14,387,048 | 1,109,256 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,886,473 | 846,615 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $48,514,840 | 3,387,908 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $43,025,002 | 3,156,640 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $66,625,581 | 4,067,496 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $36,207,284 | 2,151,354 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $48,601,617 | 2,661,644 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $35,135,425 | 1,930,518 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $57,069,391 | 3,198,957 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $55,546,474 | 3,097,963 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $46,519,168 | 3,064,504 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||